No, MK-677 is not a SARM. It is a growth hormone secretagogue, a completely different class of compound that works through a completely different mechanism. The confusion exists because MK-677 is routinely sold alongside actual SARMs on the same websites and in the same product lineups, leading many people to assume it belongs to the same category.
How MK-677 Actually Works
MK-677, also known as ibutamoren, is an orally active, non-peptide growth hormone secretagogue. It mimics the hunger hormone ghrelin by binding to ghrelin receptors in the brain, which signals the pituitary gland to release more growth hormone into the bloodstream. That elevated growth hormone then triggers the liver to produce more IGF-1, a secondary hormone involved in tissue growth and repair.
The key point: MK-677 has zero interaction with androgen receptors. It does not bind to them, activate them, or modulate them in any way. Its entire mechanism is rooted in the growth hormone pathway, not the testosterone pathway.
How SARMs Work (And Why They’re Different)
Selective androgen receptor modulators are synthetic compounds that bind directly to androgen receptors, the same receptors that testosterone activates. SARMs were designed to trigger muscle and bone growth while producing fewer of the unwanted effects that steroids cause in organs like the prostate, skin, and liver. Examples include ostarine, ligandrol (LGD-4033), andarine, and YK-11.
The “selectivity” in SARMs comes not from differences in the androgen receptor itself but from variations in the regulatory proteins that exist in different tissues. These cofactors modulate how strongly the receptor responds in a given organ, which is why SARMs preferentially activate growth in muscle and bone. That selectivity is relative, though. SARMs still stimulate androgen receptors in other tissues to some degree, which is why they can still cause side effects related to hormonal suppression.
MK-677 shares none of this biology. It doesn’t touch the androgen receptor system at all.
Why MK-677 Gets Mislabeled as a SARM
The mislabeling is almost entirely a product of how these compounds are marketed and sold. Online retailers that sell SARMs typically stock MK-677 right alongside them, often under a single “SARMs” category. From the seller’s perspective, these are all performance-enhancing research chemicals appealing to the same customer base, so they get lumped together for convenience.
A study examining seized products sold as sports performance enhancers found that ibutamoren was actually the single most commonly identified compound, ahead of well-known SARMs like ligandrol and ostarine. The same study noted that 24% of these products were marketed as dietary supplements, meaning buyers often had no idea they were taking an unapproved pharmaceutical compound. When MK-677 shows up in the same seized shipments, on the same product pages, and in the same forum discussions as SARMs, the lines blur quickly for anyone who isn’t reading the pharmacology.
Side Effects Reflect Its Unique Mechanism
Because MK-677 works through the growth hormone pathway rather than the androgen pathway, its side effect profile looks nothing like that of a SARM. SARMs can suppress natural testosterone production, lower HDL cholesterol, and in some cases cause liver stress. MK-677 doesn’t do any of those things, but it brings its own set of concerns tied to elevated growth hormone and ghrelin activity.
The most noticeable effect is increased appetite. In a year-long randomized controlled trial in healthy older adults, 67% of participants taking MK-677 reported appetite increases compared to 36% on placebo. For about half of those people, the increased hunger faded within three months, while it took longer for others.
MK-677 also raises blood sugar. In the same trial, fasting glucose increased by an average of 5 mg/dL, and HbA1c (a marker of long-term blood sugar control) rose by 0.2%. These are statistically significant but small changes in healthy individuals. Insulin sensitivity also declined over 12 months. For someone already at risk of type 2 diabetes, these shifts could be more meaningful.
Other reported side effects included mild, temporary swelling in the lower legs (44% on MK-677 vs. 27% on placebo) and transient muscle pain (33% vs. 9%). Both tended to resolve on their own.
Regulatory and Anti-Doping Status
MK-677 is not approved by the FDA for any use. The agency has issued warnings about products containing hidden ibutamoren, noting that its safety and efficacy have not been established through the approval process. It remains an investigational compound.
The World Anti-Doping Agency prohibits MK-677 under a completely separate category from SARMs on its banned substances list, which further illustrates the distinction. SARMs fall under “anabolic agents” (category S1), while MK-677 is listed under “peptide hormones, growth factors, related substances, and mimetics” (category S2), specifically in the growth hormone secretagogue subcategory alongside compounds like ghrelin and capromorelin.
If you’re subject to drug testing in any competitive sport, MK-677 is banned. But it’s banned for being a growth hormone secretagogue, not for being a SARM, because it isn’t one.